Cited 0 times in Scipus Cited Count

The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume

DC Field Value Language
dc.contributor.authorCho, KC-
dc.contributor.authorSon, NH-
dc.contributor.authorGwon, SH-
dc.contributor.authorChoi, JW-
dc.contributor.authorJung, WS-
dc.date.accessioned2024-03-14T04:52:38Z-
dc.date.available2024-03-14T04:52:38Z-
dc.date.issued2024-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/32351-
dc.description.abstractThis study aimed to evaluate the safety and efficacy of intra-arterial (IA) administration of low- dose tirofiban during endovascular therapy in patients with large ischemic core volumes on initial brain CT. Patients were divided into two groups based on the use of IA tirofiban. We identified 87 patients (16 and 71 patients in the tirofiban and no-tirofiban groups, respectively) with acute ischemic stroke due to intracranial artery occlusion who underwent endovascular therapy with a low Alberta Stroke Program Early CT scores (2–5). Multivariate logistic regression analysis revealed no association between IA tirofiban administration and serious postprocedural hemorrhagic complications (adjusted odds ratio (aOR), 0.720; 95% confidence interval (CI) 0.099–5.219; p = 0.960), any radiologic hemorrhage (aOR 0.076; 95% CI 0.003–2.323; p = 0.139), or 3-month mortality (aOR, 0.087; 95% CI 0.005–1.501; p = 0.093). However, IA tirofiban was associated with a lower 90-day mRS score (aOR, 0.197; 95% CI 0.015–1.306; p = 0.017) and change of NIHSS compared with baseline (aOR, 0.698; 95% CI 0.531–0.917; p = 0.010). IA tirofiban administration during endovascular therapy in patients with large ischemic core volumes may be effective and safe.-
dc.language.isoen-
dc.subject.MESHBrain Ischemia-
dc.subject.MESHEndovascular Procedures-
dc.subject.MESHFibrinolytic Agents-
dc.subject.MESHHumans-
dc.subject.MESHIschemic Stroke-
dc.subject.MESHStroke-
dc.subject.MESHTirofiban-
dc.subject.MESHTreatment Outcome-
dc.titleThe safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume-
dc.typeArticle-
dc.identifier.pmid38336813-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10858233-
dc.subject.keywordAcute ischemic stroke-
dc.subject.keywordAlberta Stroke Program Early CT Score-
dc.subject.keywordEndovascular therapy-
dc.subject.keywordTirofiban-
dc.contributor.affiliatedAuthorChoi, JW-
dc.contributor.affiliatedAuthorJung, WS-
dc.type.localJournal Papers-
dc.identifier.doi10.1038/s41598-024-53715-8-
dc.citation.titleScientific reports-
dc.citation.volume14-
dc.citation.number1-
dc.citation.date2024-
dc.citation.startPage3353-
dc.citation.endPage3353-
dc.identifier.bibliographicCitationScientific reports, 14(1). : 3353-3353, 2024-
dc.identifier.eissn2045-2322-
dc.relation.journalidJ020452322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiology
Files in This Item:
38336813.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse